Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Current Neurology and Neuroscience Reports
Erschienen in: Current Neurology and Neuroscience Reports 9/2016

01.09.2016 | Critical Care (SA Mayer, Section Editor)

ICU Management of the Potential Organ Donor: State of the Art

verfasst von: Carolina B. Maciel, David M. Greer

Erschienen in: Current Neurology and Neuroscience Reports | Ausgabe 9/2016

Einloggen, um Zugang zu erhalten

Abstract

End-organ failure is associated with high mortality and morbidity, in addition to increased health care costs. Organ transplantation is the only definitive treatment that can improve survival and quality of life in such patients; however, due to the persistent mismatch between organ supply and demand, waiting lists continue to grow across the world. Careful intensive care management of the potential organ donor with goal-directed therapy has the potential to optimize organ function and improve donation yield.
Literatur
1.
2.
Wolfe RA et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341(23):1725–30.CrossRefPubMed
3.
4.
Cleiren MP, Van Zoelen AA. Post-mortem organ donation and grief: a study of consent, refusal and well-being in bereavement. Death Stud. 2002;26(10):837–49.CrossRefPubMed
5.
Merchant SJ et al. Exploring the psychological effects of deceased organ donation on the families of the organ donors. Clin Transplant. 2008;22(3):341–7.CrossRefPubMed
6.
Angel LFLF. Impact of a lung transplantation donor-management protocol on lung donation and recipient outcomes. Am J Respir Crit Care Med. 2006;174(6):710–6.CrossRefPubMed
7.
Salim AA. The effect of a protocol of aggressive donor management: implications for the national organ donor shortage. J Trauma: Inj Infect Crit Care. 2006;61(2):429–35.CrossRef
8.
Singbartl KK. Intensivist-led management of brain-dead donors is associated with an increase in organ recovery for transplantation. Am J Transplant. 2011;11(7):1517–21.CrossRefPubMed
9.
Malinoski DJ et al. The impact of meeting donor management goals on the number of organs transplanted per donor: results from the United Network for Organ Sharing Region 5 prospective donor management goals study. Crit Care Med. 2012;40(10):2773–80.CrossRefPubMed
10.
Callahan DS et al. Trends in organ donor management: 2002 to 2012. J Am Coll Surg. 2014;219(4):752–6.CrossRefPubMed
11.
Abuanzeh RR. Early donor management increases the retrieval rate of hearts for transplantation in marginal donors. Eur J Cardiothorac Surg. 2015;47(1):72–7.CrossRefPubMed
12.
Patel MS et al. The impact of meeting donor management goals on the number of organs transplanted per expanded criteria donor: a prospective study from the UNOS Region 5 Donor Management Goals Workgroup. JAMA Surg. 2014;149(9):969–75.CrossRefPubMed
13.
Healthcare, E.D.f.t.Q.o.M. International figures on donation and transplantation 2014. 2014.
14.
E. Committee. Recommendations for nonheartbeating organ donation. A position paper by the Ethics Committee, American College of Critical Care Medicine, Society of Critical Care Medicine. Crit Care Med. 2001;29(9):1826–31.CrossRef
15.
16.
M. Consultants. Guidelines for the determination of death. Report of the medical consultants on the diagnosis of death to the President’s Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. JAMA. 1981;246(19):2184–6.CrossRef
17.
18.•
Shemie SD et al. International guideline development for the determination of death. Intensive Care Med. 2014;40(6):788–97. Of importance: First international initiative deriving international standards for death determination. CrossRefPubMedPubMedCentral
19.
Bernat JLJL. The circulatory-respiratory determination of death in organ donation. Crit Care Med. 2010;38(3):963–70.CrossRefPubMed
20.
Munshi L, Keshavjee S, Cypel M. Donor management and lung preservation for lung transplantation. Lancet Respir Med. 2013;1(4):318–28.CrossRefPubMed
21.
Bendorf A et al. An international comparison of the effect of policy shifts to organ donation following cardiocirculatory death (DCD) on donation rates after brain death (DBD) and transplantation rates. PLoS One. 2013;8(5), e62010.CrossRefPubMedPubMedCentral
22.
Blackstock MJ, Ray DC. Organ donation after circulatory death: an update. Eur J Emerg Med. 2014;21(5):324–9.CrossRefPubMed
23.
Kootstra GG. Categories of non-heart-beating donors. Transplant Proc. 1995;27(5):2893.PubMed
24.
25.
Fugate JE et al. Variability in donation after cardiac death protocols: a national survey. Transplantation. 2011;91(4):386–9.PubMed
26.
Medicine, I.o., Non-heart-beating organ transplantation: medical and ethical issues in procurement, in non-heart-beating organ transplantation: medical and ethical issues in procurement. 1997, 1997 by the National Academy of Sciences: Washington, DC.
27.
Sheth KN et al. Autoresuscitation after asystole in patients being considered for organ donation. Crit Care Med. 2012;40(1):158–61.CrossRefPubMed
28.
Bernat JL et al. Report of a National Conference on Donation after cardiac death. Am J Transplant. 2006;6(2):281–91.CrossRefPubMed
29.
Lewis J et al. Development of the University of Wisconsin donation After Cardiac Death Evaluation Tool. Prog Transplant. 2003;13(4):265–73.CrossRefPubMed
30.
DeVita MA et al. Donors after cardiac death: validation of identification criteria (DVIC) study for predictors of rapid death. Am J Transplant. 2008;8(2):432–41.CrossRefPubMed
31.
Yee AH et al. Factors influencing time to death after withdrawal of life support in neurocritical patients. Neurology. 2010;74(17):1380–5.CrossRefPubMed
32.
Rabinstein AA et al. Prediction of potential for organ donation after cardiac death in patients in neurocritical state: a prospective observational study. Lancet Neurol. 2012;11(5):414–9.CrossRefPubMed
33.
de Groot YJ et al. External validation of a prognostic model predicting time of death after withdrawal of life support in neurocritical patients. Crit Care Med. 2012;40(1):233–8.CrossRefPubMed
34.•
He X et al. Nomogram for predicting time to death after withdrawal of life-sustaining treatment in patients with devastating neurological injury. Am J Transplant. 2015;15(8):2136–42. Of importance: First complete nomogram predicting time to death following withdrawal of life-sustaining therapies in neurocritically ill patients that included several neurologic variables. CrossRefPubMed
35.
He X et al. The development and validation of a nomogram for identification of potential donation after cardiac death donors. 2015. Am J Transplant.
36.
Medicine, I.o., Non-heart-beating organ transplantation: practice and protocols, in non-heart-beating organ transplantation: practice and protocols. 2000, 2000 by the National Academy of Sciences: Washington, DC.
37.
Reich DJ et al. ASTS recommended practice guidelines for controlled donation after cardiac death organ procurement and transplantation. Am J Transplant. 2009;9(9):2004–11.CrossRefPubMed
38.
Detry O et al. Categories of donation after cardiocirculatory death. Transplant Proc. 2012;44(5):1189–95.CrossRefPubMed
39.
Society, B.T. National standards for organ retrieval from deceased donors. 2013.
40.
Abt P et al. Liver transplantation from controlled non-heart-beating donors: an increased incidence of biliary complications. Transplantation. 2003;75(10):1659–63.CrossRefPubMed
41.
42.
Lee KW et al. Factors affecting graft survival after liver transplantation from donation after cardiac death donors. Transplantation. 2006;82(12):1683–8.CrossRef
43.
Locke JE et al. Outcomes of kidneys from donors after cardiac death: implications for allocation and preservation. Am J Transplant. 2007;7(7):1797–807.CrossRefPubMed
44.
Phua J et al. Pro/con debate: in patients who are potential candidates for organ donation after cardiac death, starting medications and/or interventions for the sole purpose of making the organs more viable is an acceptable practice. Crit Care. 2007;11(2):211.CrossRefPubMedPubMedCentral
45.
Mateos-Rodríguez AA. Kidney transplant function using organs from non-heart-beating donors maintained by mechanical chest compressions. Resuscitation. 2010;81(7):904–7.CrossRefPubMed
46.
47.
Wilkinson D, Savulescu J. Should we allow organ donation euthanasia? Alternatives for maximizing the number and quality of organs for transplantation. Bioethics. 2012;26(1):32–48.CrossRefPubMedPubMedCentral
48.
Mollaret P, Goulon M. [The depassed coma (preliminary memoir)]. Rev Neurol (Paris). 1959;101:3–15.
49.
Wertheimer P, Jouvet M, Descotes J. Diagnosis of death of the nervous system in comas with respiratory arrest treated by artificial respiration. Presse Med. 1959;67(3):87–8.PubMed
50.
51.
A.H. Committee. A definition of irreversible coma. Report of the Ad Hoc Committee of the Harvard Medical School to Examine the Definition of Brain Death. JAMA. 1968;205(6):337–40.CrossRef
52.
Wijdicks EF et al. Evidence-based guideline update: determining brain death in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2010;74(23):1911–8.CrossRefPubMed
53.
Transplant., N.B.a. Transplant activity in the UK. Activity report 2014/15. 2014.
54.
OPTN/UNOS OPTN/UNOS OPO Committee Report. 2008.
55.
de Groot YJ et al. Imminent brain death: point of departure for potential heart-beating organ donor recognition. Intensive Care Med. 2010;36(9):1488–94.CrossRefPubMedPubMedCentral
56.
Wijdicks, E.F.M.E.F., Determining brain death. Continuum (Minneapolis, Minn.), 2015. 21(5 neurocritical care): pp. 1411-1424.
57.
Hwang DY, Gilmore EJ, Greer DM. Assessment of brain death in the neurocritical care unit. Neurosurg Clin N Am. 2013;24(3):469–82.CrossRefPubMed
58.
Saposnik G et al. Problems associated with the apnea test in the diagnosis of brain death. Neurol India. 2004;52(3):342–5.PubMed
59.
Denny JT et al. A new technique for avoiding barotrauma-induced complications in apnea testing for brain death. J Clin Neurosci. 2015;22(6):1021–4.CrossRefPubMed
60.
61.
Solek-Pastuszka J et al. Evolution of apnoea test in brain death diagnostics. Anaesth Intensive Ther. 2015;47(4):363–7.CrossRef
62.
Wieczorek A, Gaszynski T. Boussignac CPAP system for brain death confirmation with apneic test in case of acute lung injury/adult respiratory distress syndrome—series of cases. Ther Clin Risk Manag. 2015;11:961–5.PubMedPubMedCentral
63.
Giani, M.M., Apnea test during brain death assessment in mechanically ventilated and ECMO patients. Intensive Care Med. 2015.
64.
Anthony DC et al. The systemic response to brain injury and disease. Brain Behav Immun. 2012;26(4):534–40.CrossRefPubMed
65.
Watts RPRP. Inflammatory signalling associated with brain dead organ donation: from brain injury to brain stem death and posttransplant ischaemia reperfusion injury. J Transplant. 2013;2013(2):1–19.CrossRef
66.
Lee ST et al. Cholinergic anti-inflammatory pathway in intracerebral hemorrhage. Brain Res. 2010;1309:164–71.CrossRefPubMed
67.
Adrie C et al. Immune status and apoptosis activation during brain death. Shock. 2010;33(4):353–62.CrossRefPubMed
68.
Hoeger S et al. Modulation of brain dead induced inflammation by vagus nerve stimulation. Am J Transplant. 2010;10(3):477–89.CrossRefPubMed
69.
Skrabal CA et al. Organ-specific regulation of pro-inflammatory molecules in heart, lung, and kidney following brain death. J Surg Res. 2005;123(1):118–25.CrossRefPubMed
70.
Schrader H, Hall C, Zwetnow NN. Effects of prolonged supratentorial mass expansion on regional blood flow and cardiovascular parameters during the Cushing response. Acta Neurol Scand. 1985;72(3):283–94.CrossRefPubMed
71.
72.
Berman M et al. Is stress cardiomyopathy the underlying cause of ventricular dysfunction associated with brain death? J Heart Lung Transplant. 2010;29(9):957–65.CrossRefPubMed
73.
Salim AA. Complications of brain death: frequency and impact on organ retrieval. Am Surg. 2006;72(5):377.PubMed
74.
Smith M. Physiologic changes during brain stem death—lessons for management of the organ donor. J Heart Lung Transplant. 2004;23(9 Suppl):S217–22.CrossRefPubMed
75.
Avlonitis VS et al. The hemodynamic mechanisms of lung injury and systemic inflammatory response following brain death in the transplant donor. Am J Transplant. 2005;5(4 Pt 1):684–93.CrossRefPubMed
76.
Chen EP et al. Hormonal and hemodynamic changes in a validated animal model of brain death. Crit Care Med. 1996;24(8):1352–9.CrossRefPubMed
77.
Klein AS et al. Organ donation and utilization in the United States, 1999–2008. Am J Transplant. 2010;10(4 Pt 2):973–86.CrossRefPubMed
78.
Westendorp WH, Leuvenink HG, Ploeg RJ. Brain death induced renal injury. Curr Opin Organ Transplant. 2011;16(2):151–6.CrossRefPubMed
79.
Ramjug S, Hussain N, Yonan N. Prolonged time between donor brain death and organ retrieval results in an increased risk of mortality in cardiac transplant recipients. Interact Cardiovasc Thorac Surg. 2011;12(6):938–42.CrossRefPubMed
80.
Dikdan GS, Mora-Esteves C, Koneru B. Review of randomized clinical trials of donor management and organ preservation in deceased donors: opportunities and issues. Transplantation. 2012;94(5):425–41.CrossRefPubMed
81.
Macdonald PS et al. A systematic review and meta-analysis of clinical trials of thyroid hormone administration to brain dead potential organ donors. Crit Care Med. 2012;40(5):1635–44.CrossRefPubMed
82.
Sharpe MDMD. Oral and intravenous thyroxine (T4) achieve comparable serum levels for hormonal resuscitation protocol in organ donors: a randomized double-blinded study. Can J Anesth. 2013;60(10):998–1002.CrossRefPubMed
83.
Pinsard M et al. Interest of low-dose hydrocortisone therapy during brain-dead organ donor resuscitation: the CORTICOME study. Crit Care. 2014;18(4):R158.CrossRefPubMedPubMedCentral
84.••
Kotloff RM et al. Management of the potential organ donor in the ICU: Society of Critical Care Medicine/American College of Chest Physicians/Association of Organ Procurement Organizations Consensus Statement. Crit Care Med. 2015;43(6):1291–325. First guidelines for the critical care management of the potential organ donor. CrossRefPubMed
85.
Mi Z et al. The optimal hormonal replacement modality selection for multiple organ procurement from brain-dead organ donors. Clin Epidemiol. 2015;7:17–27.PubMed
86.
Hadian M et al. Cross-comparison of cardiac output trending accuracy of LiDCO, PiCCO, FloTrac and pulmonary artery catheters. Crit Care. 2010;14(6):R212.CrossRefPubMedPubMedCentral
87.
Al-Khafaji A et al. Protocolized fluid therapy in brain-dead donors: the multicenter randomized MOnIToR trial. Intensive Care Med. 2015;41(3):418–26.CrossRefPubMedPubMedCentral
88.
89.
Schnuelle P et al. Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial. JAMA. 2009;302(10):1067–75.CrossRefPubMed
90.
Wang Z et al. Stimulation of dopamine D3 receptor attenuates renal ischemia-reperfusion injury via increased linkage with Galpha12. Transplantation. 2015;99(11):2274–84.CrossRefPubMed
91.
Mascia L et al. Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: a randomized controlled trial. JAMA. 2010;304(23):2620–7.CrossRefPubMed
92.
Minambres E et al. Lung donor treatment protocol in brain dead-donors: a multicenter study. J Heart Lung Transplant. 2015;34(6):773–80.CrossRefPubMed
93.
Minambres E et al. Impact of restrictive fluid balance focused to increase lung procurement on renal function after kidney transplantation. Nephrol Dial Transplant. 2010;25(7):2352–6.CrossRefPubMed
94.
Miñambres EE. Aggressive lung donor management increases graft procurement without increasing renal graft loss after transplantation. Clin Transpl. 2013;27(1):52–9.CrossRef
95.
Prodhan P et al. Inhaled nitric oxide in neurogenic cardiopulmonary dysfunction: implications for organ donation. Transplant Proc. 2004;36(9):2570–2.CrossRefPubMed
96.
Park ES et al. Inhaled nitric oxide for the brain dead donor with neurogenic pulmonary edema during anesthesia for organ donation: a case report. Korean J Anesthesiol. 2014;67(2):133–8.CrossRefPubMedPubMedCentral
97.
Ware LBL. A randomized trial of the effects of nebulized albuterol on pulmonary edema in brain-dead organ donors. Am J Transplant. 2014;14(3):621.CrossRefPubMedPubMedCentral
98.
Andres A et al. Lower rate of family refusal for organ donation in non-heart-beating versus brain-dead donors. Transplant Proc. 2009;41(6):2304–5.CrossRefPubMed
99.
Volk ML et al. Attitudes of the American public toward organ donation after uncontrolled (sudden) cardiac death. Am J Transplant. 2010;10(3):675–80.CrossRefPubMed
100.
Niemann CU et al. Therapeutic hypothermia in deceased organ donors and kidney-graft function. N Engl J Med. 2015;373(5):405–14.CrossRefPubMed
101.
Evrard P. Belgian modified classification of Maastricht for donors after circulatory death. Transplant Proc. 2014;46(9):3138–42.CrossRefPubMed
102.
Trasplantes, O.N.d. Donation after circulatory death in Spain: current situation and recommendations. National Consensus Document. 2012.
103.
Dujardin KS et al. Myocardial dysfunction associated with brain death: clinical, echocardiographic, and pathologic features. J Heart Lung Transplant. 2001;20(3):350–7.CrossRefPubMed
104.
Gramm HJ et al. Acute endocrine failure after brain death? Transplantation. 1992;54(5):851–7.CrossRefPubMed
105.
Wind JJ. Preservation of kidneys from controlled donors after cardiac death. Br J Surg. 2011;98(9):1260–6.CrossRefPubMed
106.
Reznik ON et al. Uncontrolled donors with controlled reperfusion after sixty minutes of asystole: a novel reliable resource for kidney transplantation. PLoS One. 2013;8(5), e64209.CrossRefPubMedPubMedCentral
107.
Barlow AD, Hosgood SA, Nicholson ML. Current state of pancreas preservation and implications for DCD pancreas transplantation. Transplantation. 2013;95(12):1419–24.CrossRefPubMed
108.
Morrissey PE, Monaco AP. Donation after circulatory death: current practices, ongoing challenges, and potential improvements. Transplantation. 2014;97(3):258–64.CrossRefPubMed
109.
110.
Dhital KK et al. Adult heart transplantation with distant procurement and ex-vivo preservation of donor hearts after circulatory death: a case series. Lancet. 2015;385(9987):2585–91.CrossRefPubMed
111.
Chaumont M et al. Delayed graft function in kidney transplants: time evolution, role of acute rejection, risk factors, and impact on patient and graft outcome. J Transplant. 2015;2015:163757.CrossRefPubMedPubMedCentral
Metadaten
Titel
ICU Management of the Potential Organ Donor: State of the Art
verfasst von
Carolina B. Maciel
David M. Greer
Publikationsdatum
01.09.2016
Verlag
Springer US
Erschienen in
Current Neurology and Neuroscience Reports / Ausgabe 9/2016
Print ISSN: 1528-4042
Elektronische ISSN: 1534-6293
DOI
https://doi.org/10.1007/s11910-016-0682-1

Weitere Artikel der Ausgabe 9/2016

Current Neurology and Neuroscience Reports 9/2016 Zur Ausgabe

Sleep (M Thorpy and M Billiard, Section Editors)

Sleep Disturbances in Frontotemporal Dementia

Epilepsy (CW Bazil, Section Editor)

Pharmacological Treatment of Drug-Resistant Epilepsy in Adults: a Practical Guide

Behavior (H Kirshner, Section Editor)

A Neuropsychological Perspective on Abstract Word Representation: From Theory to Treatment of Acquired Language Disorders

Neuro-Oncology (LE Abrey, Section Editor)

Chemotherapy-Related Neurotoxicity

Critical Care (SA Mayer, Section Editor)

Hypothermia for Increased Intracranial Pressure: Is It Dead?

Behavior (H Kirshner, Section Editor)

Anosognosia in Dementia

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise